Skip to main content
SyntekaBio,Inc. logo

SyntekaBio,Inc. — Investor Relations & Filings

Ticker · 226330 ISIN · KR7226330009 KO Professional, scientific and technical activities
Open in API
Filings indexed 322 across all filing types
Latest filing 2025-09-26 Capital/Financing Update
Country KR South Korea
Listing KO 226330

About SyntekaBio,Inc.

https://www.syntekabio.com/

SyntekaBio is an AI-driven drug discovery company that utilizes its proprietary supercomputing infrastructure, the AI Bio-Supercom Center, to accelerate pharmaceutical development. The company's core technology, the DeepMatcher® platform, underpins a suite of services for discovering small molecules, antibodies, and neoantigens for personalized cancer vaccines. A key offering is LaunchPad, a factory-like system that continuously generates a stream of 'off-the-shelf' drug candidates for numerous disease targets, aiming to expedite the path to IND-enabling studies. SyntekaBio delivers its solutions through comprehensive discovery partnerships and a modular, cloud-based Software as a Service (SaaS) platform, STB CLOUD, providing researchers with automated tools for drug development and genomics analysis.

Recent filings

Filing Released Lang Actions
[기재정정]증권신고서(지분증권)
Capital/Financing Update Classification · 85% confidence The document is a Korean “증권신고서(지분증권)” – essentially an amended securities registration statement (prospectus) for an equity offering, detailing risk factors, use of proceeds, and other fundraising/legal disclosures. It is not an AGM material, earnings release, or annual/interim report but a full offering filing related to capital raising. This aligns with “Capital/Financing Update” (CAP).
2025-09-26 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on the Mass Holding of Shares, etc.' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details the acquisition of convertible bonds by Sangsangin Savings Bank in Syntekabio. This type of filing is a mandatory disclosure to financial regulators regarding significant changes in shareholding or potential equity ownership (like convertible bonds) and does not fit into categories like Annual Reports, Earnings Releases, or Investor Presentations. Therefore, it is classified as a Regulatory Filing (RNS).
2025-09-19 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as a 5% report). It details the shareholding status of the major shareholder (Jung Jong-sun) and special related parties of Syntekabio, specifically noting the release of a stock collateral agreement. This falls under the category of Major Shareholding Notification.
2025-09-15 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) from Syntekabio, specifically detailing the 'Decision to Issue Convertible Bonds' (전환사채권 발행결정). It includes detailed terms of the bond issuance, such as interest rates, conversion prices, call/put options, and collateral information. This type of filing is a standard regulatory disclosure in the Korean market for capital raising activities, which falls under the 'Capital/Financing Update' category.
2025-09-12 Korean
증권발행결과(자율공시)
Capital/Financing Update Classification · 100% confidence The document is a 'Securities Issuance Result' (증권 발행결과) announcement regarding the issuance of private convertible bonds (전환사채). It details the issuance amount, payment date, and the nature of the securities. This falls under the category of company financing and capital structure updates.
2025-09-12 Korean
단기차입금감소결정(자율공시)
Capital/Financing Update Classification · 100% confidence The document is a regulatory filing from Syntekabio regarding a decision to reduce short-term borrowings (repayment of debt). This falls under financing activities and capital structure changes. Since it specifically details a change in debt/financing, it aligns with the 'Capital/Financing Update' category.
2025-09-12 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.